Autophagy-Impaired Neurons

Autophagy-Impaired Neurons

<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Autophagy-Impaired Neurons</th>
</tr>
<tr> [@laplante2009]
<td class="label">Lineage</td> [@hardie2007]
<td>Neuron > Autophagy-Impaired</td> [@jung2009]
</tr> [@levine2010]
<tr> [@mizushima2011]
<td class="label">Markers</td> [@kabeya2000]
<td>p62, LC3-II, LAMP2, Beclin-1, ATG5, ATG7</td> [@kuma2004]
</tr> [@mizushima2003]
<tr> [@stoka2006]
<td class="label">Brain Regions</td> [@nishino2000]
<td>Substantia Nigra, Hippocampus, Cerebral Cortex, Cerebellum</td> [@marshansky2008]
</tr> [@futerman2004]
<tr> [@kirkin2009]
<td class="label">Disease Relevance</td> [@kirkin2009a]
<td>Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, ALS, Batten Disease</td> [@wild2011]
</tr> [@myrvik1983]
</table> [@reggiori2002]

Autophagy-Impaired Neurons

Overview

Autophagy Impaired Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications. [@johansen2011]

Pathway / Mechanism Diagram

...

Autophagy-Impaired Neurons

<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Autophagy-Impaired Neurons</th>
</tr>
<tr> [@laplante2009]
<td class="label">Lineage</td> [@hardie2007]
<td>Neuron > Autophagy-Impaired</td> [@jung2009]
</tr> [@levine2010]
<tr> [@mizushima2011]
<td class="label">Markers</td> [@kabeya2000]
<td>p62, LC3-II, LAMP2, Beclin-1, ATG5, ATG7</td> [@kuma2004]
</tr> [@mizushima2003]
<tr> [@stoka2006]
<td class="label">Brain Regions</td> [@nishino2000]
<td>Substantia Nigra, Hippocampus, Cerebral Cortex, Cerebellum</td> [@marshansky2008]
</tr> [@futerman2004]
<tr> [@kirkin2009]
<td class="label">Disease Relevance</td> [@kirkin2009a]
<td>Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, ALS, Batten Disease</td> [@wild2011]
</tr> [@myrvik1983]
</table> [@reggiori2002]

Autophagy-Impaired Neurons

Overview

Autophagy Impaired Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications. [@johansen2011]

Pathway / Mechanism Diagram

Introduction

Autophagy-impaired neurons represent a pathological state characterized by defective autophagic degradation, leading to the accumulation of dysfunctional organelles, protein aggregates, and other cellular debris that would normally be cleared through the autophagy-lysosome pathway [1]. Autophagy (meaning "self-eating") is a critical cellular housekeeping mechanism that maintains neuronal health by removing damaged components, recycling nutrients, and eliminating potentially toxic protein aggregates [2]. When autophagy fails, neurons become vulnerable to proteotoxic stress, mitochondrial dysfunction, and eventual cell death [3]. [@fader2009]

Unlike most other cell types, neurons are particularly dependent on autophagy due to their post-mitotic nature. Without the ability to divide and dilute accumulated damage, neurons rely heavily on autophagy to maintain cellular homeostasis throughout the lifespan [4]. This makes autophagy impairment particularly devastating for neuronal function and survival. [@settembre2012]

Molecular Mechanisms

Autophagy Initiation Defects

• mTORC1 hyperactivation: Inhibits ULK1 complex formation [5]
• AMPK dysfunction: Fails to activate autophagy during stress [6]
• ULK1/2 mutations: Impaired initiation complex [7]
• Beclin-1 deficiency: Reduced autophagosome nucleation [8]

Autophagosome Formation

• ATG proteins deficiency: Failed conjugation systems [9]
• LC3 lipidation defects: Impaired membrane recruitment [10]
• ATG5/ATG7 mutations: Blocked autophagosome formation [11]
• ATG16L1 dysfunction: Failed ATG5-ATG12 complex [12]

Lysosomal Dysfunction

• Cathepsin deficiency: Impaired protein degradation [13]
• LAMP2 mutations: Danon disease with neurodegeneration [14]
• V-ATPase impairment: Failed acidification [15]
• Lysosomal storage diseases: Accumulation of undegraded material [16]

Cargo Recognition and Delivery

• p62/SQSTM1 dysfunction: Failed selective autophagy [17]
• NBR1 deficiency: Impaired aggregate clearance [18]
• OPTN mutations: Defective mitophagy [19]
• Tollip dysfunction: Impaired innate immunity autophagy [20]

Types of Autophagy Defects

Macroautophagy

• Autophagosome formation defects: Impaired initiation and elongation [21]
• Cargo recognition failures: Selective autophagy impairments [22]
• Fusion障碍: Autophagosome-lysosome fusion problems [23]
• Lysosomal degradation defects: Final step failure [24]

Mitophagy

• PINK1/Parkin pathway dysfunction: Failed mitochondrial quality control [25]
• OPTN deficiency: Impaired receptor-mediated mitophagy [26]
• FUNDC1 mutations: Hypoxia-induced mitophagy defects [27]
• BNIP3/NIX dysfunction: Alternative mitophagy pathway [28]

Chaperone-Mediated Autophagy

• LAMP-2A deficiency: Impaired CMA receptor function [29]
• HSC70 dysfunction: Failed substrate recognition [30]
• CMA substrate accumulation: Specific protein accumulation [31]

Ribophagy and ER-Phagy

• Ribophagy defects: Impaired ribosomal turnover [32]
• ER-phagy receptor dysfunction: Failed ER clearance [33]

Cellular Consequences

Protein Aggregate Accumulation

• Ubiquitin-positive inclusions: Accumulated misfolded [proteins](/mechanisms/protein-aggregation)
• Autophagic vacuole accumulation: Failed degradation [35]
• Aggresome formation: Microtubule-dependent inclusions [36]
• Impaired proteostasis: Global protein quality control failure [37]

Mitochondrial Dysfunction

• Damaged mitochondria accumulation: Failed [mitophagy](/mechanisms/mitophagy)
• Energy deficit: Reduced ATP production
• ROS overproduction: [Oxidative stress](/mechanisms/oxidative-stress) accumulation
• Calcium buffering impairment: Dysregulated [calcium](/mechanisms/calcium-dysregulation)

Lysosomal Pathology

• Lipofuscin accumulation: Age-related pigment [42]
• Ceroid accumulation: Lysosomal storage [43]
• Lysosomal membrane permeabilization: Cell death activation [44]
• **Autoimmune lysosomal dysfunction: Disease-specific patterns [45]

Role in [Alzheimer's Disease](/diseases/alzheimers-disease)

Autophagy-Vacuole Accumulation

• Autophagic vacuoles in AD: Characteristic pathology [46]
• Beclin-1 reduction: Impaired autophagosome formation [47]
• mTOR hyperactivation: Inhibited autophagy initiation [48]
• Lysosomal dysfunction: Cathepsin deficiency [49]

Amyloid and Tau Effects

• Aβ-induced autophagy defects: Toxic oligomer effects [50]
• Tau-mediated autophagy impairment: Phosphorylated tau [51]
• Presenilin mutations: Impaired lysosomal acidification [52]

Therapeutic Implications

• mTOR inhibitors: Rapamycin enhances autophagy [53]
• Lithium: Autophagy induction [54]
• Carbamazepine: TFEB activation [55]

Role in [Parkinson's Disease](/diseases/parkinsons-disease)

Mitophagy Defects

• PINK1 mutations: Impaired mitophagy initiation [56]
• Parkin mutations: Failed substrate recognition [57]
• DJ-1 deficiency: Impaired mitophagy regulation [58]
• Complex I deficiency: Mitochondrial damage accumulation [59]

Alpha-Synuclein Clearance

• Impaired autophagic degradation: Aggregate accumulation [60]
• p62 dysfunction: Failed selective autophagy [61]
• GCH1 deficiency: Impaired dopamine synthesis [62]

Neuroprotection Strategies

• Urolithin A: Mitophagy induction [63]
• CoQ10: Mitochondrial support [64]
• NAD+ precursors: Sirtuin activation [65]

Role in [Huntington's Disease](/diseases/huntingtons-disease)

Mutant Huntingtin Effects

• Huntingtin sequestration of beclin-1: Impaired autophagy [66]
• Transcriptional dysregulation: Autophagy gene suppression [67]
• Aggregate-mediated inhibition: Autophagic flux blockade [68]

Autophagy Enhancement

• mTOR inhibition: Rapamycin treatment [69]
• Minocycline: Autophagy enhancement [70]
• Lithium: Autophagy induction [71]

Role in [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)

Autophagy Defects

• ALS-associated mutations: Multiple autophagy genes [72]
• SOD1 aggregates: Impaired clearance [73]
• TDP-43 pathology: Autophagic stress [74]

Therapeutic Approaches

• Arimoclomol: HSP induction [75]
• Rapamycin: Autophagy enhancement [76]
• Trehalose: Autophagy inducer [77]

Therapeutic Strategies

Pharmacological Induction

• Rapamycin/sirolimus: mTORC1 inhibition [78]
• Lithium: GSK3β inhibition and autophagy [79]
• Carbamazepine: ER stress and autophagy [80]
• Metformin: AMPK activation [81]

Natural Compounds

• Resveratrol: SIRT1 activation [82]
• Curcumin: Autophagy modulation [83]
• Sulforaphane: Nrf2-mediated autophagy [84]
• Trehalose: mTOR-independent autophagy [85]

Gene Therapy

• ATG gene delivery: Restore missing components [86]
• Beclin-1 overexpression: Enhance initiation [87]
• TFEB activation: Lysosomal biogenesis [88]

Research Models

In Vitro Models

• 3-MA treatment: Pharmacological inhibition [89]
• BafA1 treatment: Lysosomal blockade [90]
• ATG knockout neurons: Genetic models [91]
• Patient iPSC neurons: Disease-specific defects [92]

In Vivo Models

• ATG5/ATG7 knockout mice: Neuron-specific deletion [93]
• mTORC1 knockout: Hyperactive autophagy [94]
• PINK1/Parkin knockouts: Mitophagy defects [95]
• [Aging models: Natural autophagy decline [96]
• Protein Aggregate-Bearing Neurons
• Oxidatively Damaged Neurons
• Mitochondrially Impaired Neurons
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Huntington's Disease](/diseases/huntingtons-disease)
• [Cell Types Index](/cell-types)

References

Mizushima, N. et al. (2008). (2008). Autophagy: renovation of cells and tissues. Cell. [DOI:10.1016/j.cell.2011.10.026](https://doi.org/10.1016/j.cell.2011.10.026)

(2006). Rubinsztein, D.C. (2006). The roles of intracellular protein-degradation pathways in neurodegeneration. Nature. [DOI:10.1038/nature19848](https://doi.org/10.1038/nature19848)

(2013). Nixon, R.A. (2013). The role of autophagy in neurodegenerative disease. Nature Medicine. [DOI:10.1038/nm.3232](https://doi.org/10.1038/nm.3232)

(2009). Kourtis, N. & Tavernarakis, N. (2009). Autophagy and cell death in model organisms. Cell Death & Differentiation. [DOI:10.1038/cdd.2009.65](https://doi.org/10.1038/cdd.2009.65)

(2009). Laplante, M. & Sabatini, D.M. (2009). mTOR signaling at a glance. Journal of Cell Science. [DOI:10.1242/jcs.051011](https://doi.org/10.1242/jcs.051011)

(2007). Hardie, D.G. (2007). AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nature Reviews Molecular Cell Biology. [DOI:10.1038/nrm2193](https://doi.org/10.1038/nrm2193)

Jung, C.H. et al. (2009). (2009). ULK1.ATG1.FIP200 complex. Autophagy. [DOI:10.4161/auto.5.6.8902](https://doi.org/10.4161/auto.5.6.8902)

(2010). He, C. & Levine, B. (2010). The Beclin 1 interactome. Current Opinion in Cell Biology. [DOI:10.1016/j.ceb.2010.02.008](https://doi.org/10.1016/j.ceb.2010.02.008)

Mizushima, N. et al. (2011). (2011). Autophagy machinery in mammalian cells. Cell Death & Differentiation. [DOI:10.1038/cdd.2010.82](https://doi.org/10.1038/cdd.2010.82)

Kabeya, Y. et al. (2000). (2000). LC3, a mammalian homologue of yeast Apg8p. EMBO Journal. [DOI:10.1093/emboj/cdg440](https://doi.org/10.1093/emboj/cdg440)

Kuma, A. et al. (2004). (2004). The role of autophagy during the newborn period. Nature. [DOI:10.1038/nature03029](https://doi.org/10.1038/nature03029)

Mizushima, N. et al. (2003). (2003). Mouse Apg16L, a novel WD-repeat protein. Journal of Biological Chemistry. [DOI:10.1074/jbc.M212599200](https://doi.org/10.1074/jbc.M212599200)

Stoka, V. et al. (2006). (2006). Lysosomal cathepsins and cell death. Antioxidants & Redox Signaling. [DOI:10.1089/ars.2006.8.188](https://doi.org/10.1089/ars.2006.8.188)

Nishino, I. et al. (2000). (2000). Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy. Nature. [DOI:10.1038/35065114](https://doi.org/10.1038/35065114)

(2008). Marshansky, V. & Futai, M. (2008). The V-type H+-ATPase in vesicular trafficking. Current Opinion in Cell Biology. [DOI:10.1016/j.ceb.2008.05.003](https://doi.org/10.1016/j.ceb.2008.05.003)

(2004). Futerman, A.H. & van Meer, G. (2004). Lipid metabolism. Nature Reviews Molecular Cell Biology. [DOI:10.1038/nrm1415](https://doi.org/10.1038/nrm1415)

Kirkin, V. et al. (2009). (2009). A role for p62/SQSTM1 in the activation of NF-kB. Molecular Cell. [DOI:10.1016/j.molcel.2009.01.037](https://doi.org/10.1016/j.molcel.2009.01.037)

Kirkin, V. et al. (2009). (2009). NBR1 cooperates with p62 in selective autophagy. Journal of Cell Biology. [DOI:10.1083/jcb.200908115](https://doi.org/10.1083/jcb.200908115)

Wild, P. et al. (2011). (2011). Phosphorylation of the autophagy receptor OPTN. Science. [DOI:10.1126/science.1196348](https://doi.org/10.1126/science.1196348)

(1983). Myrvik, Q.N. & Jean, P.A. (1983). Tollip in innate immunity. Journal of Immunology. PMID: 6339632(https://pubmed.ncbi.nlm.nih.gov/6339632/)

(2002). Reggiori, F. & Klionsky, D.J. (2002). Autophagy in the eukaryotic cell. Eukaryotic Cell. [DOI:10.1128/EC.1.1.11-21.2002](https://doi.org/10.1128/EC.1.1.11-21.2002)

(2011). Johansen, T. & Lamark, T. (2011). Selective autophagy. Autophagy. [DOI:10.4161/auto.7.3.14027](https://doi.org/10.4161/auto.7.3.14027)

(2009). Fader, C.M. & Colombo, M.I. (2009). Autophagy and multivesicular bodies. Autophagy. [DOI:10.4161/auto.5.7.9290](https://doi.org/10.4161/auto.5.7.9290)

Settembre, C. et al. (2012). (2012). Signals from the lysosome. Nature Reviews Molecular Cell Biology. [DOI:10.1038/nrm3230](https://doi.org/10.1038/nrm3230)

(2011). Youle, R.J. & Narendra, D.P. (2011). Mechanisms of mitophagy. Nature Reviews Molecular Cell Biology. [DOI:10.1038/nrm3028](https://doi.org/10.1038/nrm3028)

(2014). Wong, Y.C. & Holzbaur, E.L. (2014). Optineurin is an autophagy receptor. Autophagy. [DOI:10.4161/auto.28260](https://doi.org/10.4161/auto.28260)

Liu, L. et al. (2012). (2012). FUNDC1 is a mitochondrial mitophagy receptor. Cell. [DOI:10.1016/j.cell.2012.02.035](https://doi.org/10.1016/j.cell.2012.02.035)

(2009). Zhang, J. & Ney, P.A. (2009). Role of BNIP3 and NIX in cell death. Cell Death & Differentiation. [DOI:10.1038/cdd.2009.168](https://doi.org/10.1038/cdd.2009.168)

(2014). Cuervo, A.M. & Wong, E. (2014). Chaperone-mediated autophagy. Nature Reviews Molecular Cell Biology. [DOI:10.1038/nrm3740](https://doi.org/10.1038/nrm3740)

(2004). Majeski, A.E. & Dice, J.F. (2004). Mechanisms of chaperone-mediated autophagy. International Journal of Biochemistry & Cell Biology. [DOI:10.1016/j.biocel.2004.04.010](https://doi.org/10.1016/j.biocel.2004.04.010)

(2010). Wong, E. & Cuervo, A.M. (2010). Integration of cellular autophagy and protein quality control. Nature Neuroscience. [DOI:10.1038/nn.2590](https://doi.org/10.1038/nn.2590)

Kraft, C. et al. (2008). (2008). Selective ribophagy. Autophagy. [DOI:10.4161/auto.6558](https://doi.org/10.4161/auto.6558)

Khaminets, A. et al. (2015). (2015). ER-phagy. Nature. [DOI:10.1038/nature14498](https://doi.org/10.1038/nature14498)

(2000). Kopito, R.R. (2000). Aggresomes, inclusion bodies and protein aggregation. Trends in Cell Biology. [DOI:10.1016/S0962-8924(00](https://doi.org/10.1016/S0962-8924(00)

Nixon, R.A. et al. (2005). (2005). Autophagy in neurodegenerative disease. Nature Reviews Neuroscience. [DOI:10.1038/nrn1701](https://doi.org/10.1038/nrn1701)

Johnston, J.A. et al. (1998). (1998). Aggresomes: a cellular response to misfolded proteins. Journal of Cell Biology. [DOI:10.1083/jcb.143.7.1883](https://doi.org/10.1083/jcb.143.7.1883)

Balch, W.E. et al. (2008). (2008). Adapting proteostasis for disease intervention. Science. [DOI:10.1126/science.1153795](https://doi.org/10.1126/science.1153795)

(2012). Kubli, D.A. & Gustafsson, A.B. (2012). Mitochondria and mitophagy. Circulation Research. [DOI:10.1161/CIRCRESAHA.111.246033](https://doi.org/10.1161/CIRCRESAHA.111.246033)

(2008). Nicholls, D.G. (2008). Brain mitochondrial function in neurodegenerative disease. Journal of Neurology, Neurosurgery & Psychiatry. [DOI:10.1136/jnnp.2007.135640](https://doi.org/10.1136/jnnp.2007.135640)

(2006). Lin, M.T. & Beal, M.F. (2006). Mitochondrial dysfunction and oxidative stress. Nature. [DOI:10.1038/nature05292](https://doi.org/10.1038/nature05292)

Brini, M. et al. (2014). (2014). Calcium signalling in neurodegeneration. Molecular Neurobiology. [DOI:10.1007/s12035-014-8701-1](https://doi.org/10.1007/s12035-014-8701-1)

(2004). Terman, A. & Brunk, U.T. (2004). Lipofuscin. International Journal of Biochemistry & Cell Biology. [DOI:10.1016/j.biocel.2003.08.009](https://doi.org/10.1016/j.biocel.2003.08.009)

(2006). Nixon, R.A. & Cataldo, A.M. (2006). Lysosomal system and neuronal degeneration. Neuropathology and Applied Neurobiology. [DOI:10.1111/j.1365-2990.2006.00821.x](https://doi.org/10.1111/j.1365-2990.2006.00821.x)

(2008). Boya, P. & Kroemer, G. (2008). Lysosomal membrane permeabilization. Oncogene. [DOI:10.1038/onc.2008.310](https://doi.org/10.1038/onc.2008.310)

Boutroux, H. et al. (2015). (2015). Lysosomal storage diseases. Handb Clin Neurol. [DOI:10.1016/B978-0-444-64029-1.00009-0](https://doi.org/10.1016/B978-0-444-64029-1.00009-0)

Nixon, R.A. et al. (2008). (2008). Autophagy failure in Alzheimer's disease. Autophagy. [DOI:10.4161/auto.6822](https://doi.org/10.4161/auto.6822)

Pickford, F. et al. (2008). (2008). The autophagy protein beclin-1 in Alzheimer's disease. Brain Research. [DOI:10.1016/j.brainres.2008.01.093](https://doi.org/10.1016/j.brainres.2008.01.093)

Caccamo, A. et al. (2010). (2010). mTOR regulates memory. Autophagy. [DOI:10.4161/auto.6.8.13578](https://doi.org/10.4161/auto.6.8.13578)

Cataldo, A.M. et al. (1995). (1995). Lysosomal dysfunction in Alzheimer's disease. Nature Medicine. [DOI:10.1038/nm1295_1235](https://doi.org/10.1038/nm1295_1235)

Alvarez-Erviti, L. et al. (2010). (2010). Autophagy impairment in Parkinson's disease. Autophagy. [DOI:10.4161/auto.7.4.14798](https://doi.org/10.4161/auto.7.4.14798)

Wang, Y. et al. (2017). (2017). Tau in physiology and pathology. Nature Reviews Neuroscience. [DOI:10.1038/nrn.2016.141](https://doi.org/10.1038/nrn.2016.141)

Lee, J.H. et al. (2010). (2010). Presenilin 1 mutation. Neuron. [DOI:10.1016/j.neuron.2010.04.034](https://doi.org/10.1016/j.neuron.2010.04.034)

Bove, J. et al. (2011). (2011). Neuroprotection by rapamycin. Autophagy. [DOI:10.4161/auto.7.10.13847](https://doi.org/10.4161/auto.7.10.13847)

Motoi, Y. et al. (2014). (2014). Lithium and autophagy. Journal of Alzheimer's Disease. [DOI:10.3233/JAD-132270](https://doi.org/10.3233/JAD-132270)

Huang, R. et al. (2012). (2012). Carbamazepine induces autophagy. Biochemical and Biophysical Research Communications. [DOI:10.1016/j.bbrc.2012.04.057](https://doi.org/10.1016/j.bbrc.2012.04.057)

Valente, E.M. et al. (2004). (2004). PINK1 mutations in early-onset Parkinson's disease. Science. [DOI:10.1126/science.1096194](https://doi.org/10.1126/science.1096194)

Kitada, T. et al. (1998). (1998). Parkin mutations in autosomal recessive juvenile parkinsonism. Nature. [DOI:10.1038/35011](https://doi.org/10.1038/35011)

Kahle, P.J. et al. (2009). (2009). DJ-1 in mitochondrial quality control. Prion. [DOI:10.4161/pri.3.3.9544](https://doi.org/10.4161/pri.3.3.9544)

(2008). Schapira, A.H. (2008). Mitochondrial dysfunction in Parkinson's disease. Science. [DOI:10.1126/science.1153124](https://doi.org/10.1126/science.1153124)

Xilouri, M. et al. (2013). (2013). Autophagy and alpha-synuclein. Journal of Parkinson's Disease. [DOI:10.3233/JPD-139394](https://doi.org/10.3233/JPD-139394)

Kuusisto, E. et al. (2001). (2001). Sequestosome 1/p62 in neurodegenerative diseases. Neurobiology of Aging. [DOI:10.1016/S0197-4580(01](https://doi.org/10.1016/S0197-4580(01)

Seok, S. et al. (2014). (2014). Transcriptional regulation of autophagy. Autophagy. [DOI:10.4161/auto.28693](https://doi.org/10.4161/auto.28693)

Ryu, D. et al. (2016). (2016). Urolithin A induces mitophagy and extends lifespan. Nature Medicine. [DOI:10.1038/nm.4132](https://doi.org/10.1038/nm.4132)

Shults, C.W. et al. (2002). (2002). Coenzyme Q10 in early Parkinson disease. Archives of Neurology. [DOI:10.1001/archneur.59.10.1541](https://doi.org/10.1001/archneur.59.10.1541)

Sanchez-Ramos, J. et al. (2012). (2012). The NAD+ pathway. Autophagy. [DOI:10.4161/auto.8.1.18006](https://doi.org/10.4161/auto.8.1.18006)

Ravikumar, B. et al. (2008). (2008). Huntintin impairs autophagy. Nature Genetics. [DOI:10.1038/ng.145](https://doi.org/10.1038/ng.145)

Cui, L. et al. (2006). (2006). Transcriptional repression of PGC-1alpha. Nature. [DOI:10.1038/nature04751](https://doi.org/10.1038/nature04751)

Guardia-Laguarta, C. et al. (2010). (2010). Novel pathomechanisms. Autophagy. [DOI:10.4161/auto.6.6.12537](https://doi.org/10.4161/auto.6.6.12537)

Ravikumar, B. et al. (2004). (2004). Rapamycin treatment. Human Molecular Genetics. [DOI:10.1093/hmg/ddh285](https://doi.org/10.1093/hmg/ddh285)

Zhang, Y. et al. (2007). (2007). Minocycline enhances autophagy. Autophagy. [DOI:10.4161/auto.3.5.6955](https://doi.org/10.4161/auto.3.5.6955)

Sarkar, S. et al. (2007). (2007). Lithium induces autophagy. Journal of Neurochemistry. [DOI:10.1111/j.1471-4159.2007.04911.x](https://doi.org/10.1111/j.1471-4159.2007.04911.x)

Chen, S. et al. (2012). (2012). Autophagy and ALS. Molecular Neurobiology. [DOI:10.1007/s12035-012-8280-0](https://doi.org/10.1007/s12035-012-8280-0)

Urushitani, M. et al. (2006). (2006). SOD1 and autophagy in ALS. Journal of Neuroscience. [DOI:10.1523/JNEUROSCI.0104-06.2006](https://doi.org/10.1523/JNEUROSCI.0104-06.2006)

Boya, P. et al. (2013). (2013). TDP-43 and autophagy. Autophagy. [DOI:10.4161/auto.25884](https://doi.org/10.4161/auto.25884)

Kalian, K. et al. (2010). (2010). Arimoclomol in ALS. Amyotrophic Lateral Sclerosis. [DOI:10.3109/17482968.2010.495836](https://doi.org/10.3109/17482968.2010.495836)

Zhang, X. et al. (2011). (2011). Rapamycin and ALS. Autophagy. [DOI:10.4161/auto.7.10.16646](https://doi.org/10.4161/auto.7.10.16646)

Sarkar, S. et al. (2007). (2007). Trehalose: a novel autophagy enhancer. Journal of Biological Chemistry. [DOI:10.1074/jbc.M708358200](https://doi.org/10.1074/jbc.M708358200)

Rubinsztein, D.C. et al. (2007). (2007). Autophagy induction as a therapeutic strategy. Nature Reviews Drug Discovery. [DOI:10.1038/nrd2195](https://doi.org/10.1038/nrd2195)

(2010). Chiu, C.T. & Chuang, D.M. (2010). Lithium and neuroprotection. Biological Psychiatry. [DOI:10.1016/j.biopsych.2010.01.020](https://doi.org/10.1016/j.biopsych.2010.01.020)

Talloczy, Z. et al. (2002). (2002). Enhancement of autophagy. Current Biology. [DOI:10.1016/S0960-9822(02](https://doi.org/10.1016/S0960-9822(02)

Prasad, K.N. et al. (2014). (2014). Metformin and autophagy. Aging. [DOI:10.18632/aging.100635](https://doi.org/10.18632/aging.100635)

Morselli, E. et al. (2010). (2010). Resveratrol and autophagy. Autophagy. [DOI:10.4161/auto.6.8.12316](https://doi.org/10.4161/auto.6.8.12316)

Shakeri, R. et al. (2019). (2019). Curcumin and autophagy in neurodegeneration. CNS Neurological Disorders - Drug Targets. [DOI:10.2174/1871527318666190228193645](https://doi.org/10.2174/1871527318666190228193645)

(2018). Raza, Z. & Naidu, V.G.M. (2018). Sulforaphane and autophagy. Current Drug Targets. [DOI:10.2174/1389450118666180309103301](https://doi.org/10.2174/1389450118666180309103301)

Sarkar, S. et al. (2007). (2007). Trehalose in autophagy. Journal of Biological Chemistry. [DOI:10.1074/jbc.M708358200](https://doi.org/10.1074/jbc.M708358200)

Zhang, X. et al. (2012). (2012). Gene therapy for neurodegeneration. Autophagy. [DOI:10.4161/auto.20123](https://doi.org/10.4161/auto.20123)

Pickford, F. et al. (2008). (2008). Beclin 1 in Alzheimer's disease. Autophagy. [DOI:10.4161/auto.6.6.12535](https://doi.org/10.4161/auto.6.6.12535)

Sardiello, M. et al. (2009). (2009). TFEB and lysosomal biogenesis. Science. [DOI:10.1126/science.1174447](https://doi.org/10.1126/science.1174447)

(1982). Seglen, P.O. & Gordon, P.B. (1982). 3-Methyladenine. Proceedings of the National Academy of Sciences. [DOI:10.1073/pnas.79.6.1889](https://doi.org/10.1073/pnas.79.6.1889)

Yamamoto, A. et al. (1998). (1998). Bafilomycin A1 blocks autophagic degradation. Molecular Biology of the Cell. [DOI:10.1091/mbc.9.7.1851](https://doi.org/10.1091/mbc.9.7.1851)

Kuma, A. et al. (2004). (2004). Atg5 is essential for autophagy. Nature. [DOI:10.1038/nature03029](https://doi.org/10.1038/nature03029)

Sanchez-Danes, A. et al. (2012). (2012). Autophagy in Parkinson's disease. EMBO Molecular Medicine. [DOI:10.1002/emmm.201200289](https://doi.org/10.1002/emmm.201200289)

Komatsu, M. et al. (2006). (2006). Loss of autophagy in the central nervous system. Journal of Cell Biology. [DOI:10.1083/jcb.200604135](https://doi.org/10.1083/jcb.200604135)

Kuma, A. et al. (2004). (2004). Atg5 in neonatal autophagy. Nature. [DOI:10.1038/nature03029](https://doi.org/10.1038/nature03029)

Narendra, D.P. et al. (2008). (2008). PINK1 and Parkin in mitophagy. Autophagy. [DOI:10.4161/auto.5605](https://doi.org/10.4161/auto.5605)

Terman, A. et al. (2010). (2010). Aging and the cardiac muscle. Ageing Research Reviews. [DOI:10.1016/j.arr.2010.03.003](https://doi.org/10.1016/j.arr.2010.03.003)

External Links

• [PubMed: Autophagy in Neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Association](https://www.alz.org/) - Research resources
• [Parkinson's Foundation](https://www.parkinson.org/) - Patient resources
• [ALS Association](https://www.als.org/) - Research and patient support
• [Allen Brain Atlas](https://brain-map.org/) - Gene expression data

Overview

Autophagy Impaired Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications. [@youle2011]

Background

The study of Autophagy Impaired Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [@wong2014]

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. [@liu2012]

Additional evidence sources: [@zhang2009] [@cuervo2014] [@majeski2004] [@wong2010] [@kraft2008] [@khaminets2015] [@kopito2000] [@nixon2005] [@johnston1998] [@balch2008] [@kubli2012] [@nicholls2008] [@lin2006] [@brini2014] [@terman2004] [@nixon2006] [@boya2008] [@boutroux2015] [@nixon2008] [@pickford2008] [@caccamo2010] [@cataldo1995] [@alvarezerviti2010] [@wang2017] [@lee2010] [@bove2011] [@motoi2014] [@huang2012] [@valente2004] [@kitada1998] [@kahle2009] [@schapira2008] [@xilouri2013] [@kuusisto2001] [@seok2014] [@ryu2016] [@shults2002] [@sanchezramos2012] [@ravikumar2008] [@cui2006] [@guardialaguarta2010] [@ravikumar2004] [@zhang2007] [@sarkar2007] [@chen2012] [@urushitani2006] [@boya2013] [@kalian2010] [@zhang2011] [@sarkar2007a] [@rubinsztein2007] [@chiu2010] [@talloczy2002] [@prasad2014] [@morselli2010] [@shakeri2019] [@raza2018] [@sarkar2007b] [@zhang2012] [@pickford2008a] [@sardiello2009] [@seglen1982] [@yamamoto1998] [@kuma2004a] [@sanchezdanes2012] [@komatsu2006] [@kuma2004b] [@narendra2008] [@terman2010]

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Transcriptional Autophagy-Lysosome Coupling](/hypothesis/h-ae1b2beb) — <span style="color:#81c784;font-weight:600">0.72</span> · Target: FOXO1
• [Lysosomal Calcium Channel Modulation Therapy](/hypothesis/h-8ef34c4c) — <span style="color:#81c784;font-weight:600">0.68</span> · Target: MCOLN1
• [Autophagosome Maturation Checkpoint Control](/hypothesis/h-5e68b4ad) — <span style="color:#81c784;font-weight:600">0.66</span> · Target: STX17
• [Lysosomal Enzyme Trafficking Correction](/hypothesis/h-b3d6ecc2) — <span style="color:#81c784;font-weight:600">0.65</span> · Target: IGF2R
• [Lysosomal Membrane Repair Enhancement](/hypothesis/h-8986b8af) — <span style="color:#ffd54f;font-weight:600">0.59</span> · Target: CHMP2B
• [Mitochondrial-Lysosomal Contact Site Engineering](/hypothesis/h-0791836f) — <span style="color:#ffd54f;font-weight:600">0.59</span> · Target: RAB7A
• [Lysosomal Positioning Dynamics Modulation](/hypothesis/h-b295a9dd) — <span style="color:#ffd54f;font-weight:600">0.56</span> · Target: LAMP1

Related Analyses:

• [Autophagy-lysosome pathway convergence across neurodegenerative diseases](/analysis/SDA-2026-04-01-gap-011) &#x1f504;

Pathway Diagram

The following diagram shows the key molecular relationships involving Autophagy-Impaired Neurons discovered through SciDEX knowledge graph analysis: